DEERFIELD MANAGEMENT COMPANY, L.P.
Position in LNTH — Lantheus Holdings, Inc.
CIK 1009258
NEW YORK, NY
Position in LNTH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$62,803,724
+$7,700,391 QoQ
Shares Held
827,999
0.0% QoQ
Ownership
1.27%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026DEERFIELD MANAGEMENT COMPANY, L.P. holds $924,724,739 across 6 Drug Manufacturers - Specialty & Generic names. LNTH ranks #6 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
20,206,170 | $272,985,356 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
457,000 | $270,991,860 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
15,038,000 | $143,161,760 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
3,097,790 | $94,420,639 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
610,000 | $80,361,400 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
This page
|
827,999 | $62,803,724 |
All Filings in LNTH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $62,803,724 | 827,999 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $55,103,333 | 827,999 | Shares | Defined | 2026-02-17 | |
| 2025-03-31 | $23,445,276 | 240,218 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $21,489,902 | 240,218 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $26,363,925 | 240,218 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $19,287,103 | 240,218 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $14,949,238 | 240,187 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||